| (+)-N-[(S)-α-(Chloromethyl)benzyl]acetamide | (+)-N-[(S)-α-(Chloromethyl)benzyl]acetamide | |
| N-[(S)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]acetamide | N-[(S)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]acetamide | |
| (+)-N-[(S)-2-Chloro-1-methylethyl]-N-methylformamide | (+)-N-[(S)-2-Chloro-1-methylethyl]-N-methylformamide | |
| (-)-N-[(S)-3-Chloro-1-methyl-2-oxopropyl]phthalimide | (-)-N-[(S)-3-Chloro-1-methyl-2-oxopropyl]phthalimide | |
| N-[(S)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]-4-hydroxybenzeneacetamide | N-[(S)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]-4-hydroxybenzeneacetamide | |
| N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}-N-methylmethanesulfonamide | N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}-N-methylmethanesulfonamide | |
| N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}-N-ethylmethanesulfonamide | N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}-N-ethylmethanesulfonamide | |
| N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}methanesulfonamide | N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}methanesulfonamide | |
| N-(2-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}ethyl)methanesulfonamide | N-(2-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}ethyl)methanesulfonamide | |
| N-[[(1S)-11-Bromo-1,2,7,8,13,13bβ-hexahydro-10-hydroxy[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol]-1α-yl]-2-hydroxyacetamide | N-[[(1S)-11-Bromo-1,2,7,8,13,13bβ-hexahydro-10-hydroxy[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol]-1α-yl]-2-hydroxyacetamide | 96426-93-6 |
| N-[(1S)-2β-Bromocycloheptan-1α-yl]acetamide | N-[(1S)-2β-Bromocycloheptan-1α-yl]acetamide | |
| (-)-N-[(S)-2-Bromohexanoyl]glycine | (-)-N-[(S)-2-Bromohexanoyl]glycine | |
| (-)-N-[(S)-2-Bromopropionyl]glycine | (-)-N-[(S)-2-Bromopropionyl]glycine | |
| (+)-N-[(S)-α-(Bromomethyl)benzyl]acetamide | (+)-N-[(S)-α-(Bromomethyl)benzyl]acetamide | |
| (-)-N-[(S)-3-Bromo-1-methyl-2-oxopropyl]phthalimide | (-)-N-[(S)-3-Bromo-1-methyl-2-oxopropyl]phthalimide | |
| Nα-[(2S)-3-(5-Bromo-1H-indol-3-yl)-2-aminopropionyl]-L-tryptophan | Nα-[(2S)-3-(5-Bromo-1H-indol-3-yl)-2-aminopropionyl]-L-tryptophan | |
| (-)-N-[(S)-α-(Bromoacetyl)-p-methoxyphenethyl]phthalimide | (-)-N-[(S)-α-(Bromoacetyl)-p-methoxyphenethyl]phthalimide | |
| (-)-N-[(S)-2-Bromobutyryl]glycine | (-)-N-[(S)-2-Bromobutyryl]glycine | |
| (-)-N-[(S)-2-Bromo-4-methylvaleryl]glycine | (-)-N-[(S)-2-Bromo-4-methylvaleryl]glycine | |
| N-[(1S)-2β-Bromocyclopentan-1α-yl]acetamide | N-[(1S)-2β-Bromocyclopentan-1α-yl]acetamide | |
| (-)-N-[(S)-2-Bromo-3-methylbutyryl]glycine | (-)-N-[(S)-2-Bromo-3-methylbutyryl]glycine | |
| N-[(8α,9S)-cinchonan-9-yl]-3,5-bis(trifluoroMethyl)-BenzenesulfonaMide | N-[(8α,9S)-신코난-9-일]-3,5-비스(트리플루오로메틸)-벤젠술포나미드 | 1253690-78-6 |
| N-(8α,9S)-cinchonan-9-yl-N'-[(2R)-2-pyrrolidinylMethyl]-Thiourea | N-(8α,9S)-cinchonan-9-yl-N'-[(2R)-2-pyrrolidinylMethyl]-Thiourea | 1222966-43-9 |
| N-(8α,9S)-cinchonan-9-yl-N'-[(2S)-2-pyrrolidinylMethyl]-Thiourea | N-(8α,9S)-cinchonan-9-yl-N'-[(2S)-2-pyrrolidinylMethyl]-Thiourea | 1222966-34-8 |
| NSC632839hydrochloride | NSC632839염산염 | 157654-67-6 |
| NSC 23766 (hydrochloride) | NSC 23766 (hydrochloride) | 1177865-17-6 |
| NR-LU-10 antibody | NR-LU-10 antibody | |
| (+)-N-[[(R)-N-Benzyloxycarbonyl-3-cyano-D-alanyl]oxy]succinimide | (+)-N-[[(R)-N-Benzyloxycarbonyl-3-cyano-D-alanyl]oxy]succinimide | |
| N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide | N-((R)-1-(나프탈렌-1-일)에틸)-3-(3-(트리플루오로메틸)페닐)프로판아미드 | 1005450-55-4 |
| N-[(R)-1-(1-Naphtyl)ethyl]carbamic acid (E)-3-cyclohexylallyl ester | N-[(R)-1-(1-Naphtyl)ethyl]carbamic acid (E)-3-cyclohexylallyl ester | |
| (-)-N-[(R)-2-(2-Naphtyl)propionyl]-4-morpholinecarbothioamide | (-)-N-[(R)-2-(2-Naphtyl)propionyl]-4-morpholinecarbothioamide | |
| (+)-N-[(R)-1-(1-Naphtyl)ethyl]formamide | (+)-N-[(R)-1-(1-Naphtyl)ethyl]formamide | |
| N-[(R)-1-(1-NAPHTHYL)ETHYL]PHTHALAMIC ACID | N-[(R)-1-(1-NAPHTHYL)ETHYL]PHTHALAMIC ACID | |
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67
| |
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa14-30
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa14-30
| |
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67 Control Peptide (KLH)
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67 Control Peptide (KLH)
| |
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67 Control Peptide
| NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67 Control Peptide
| |
| N-[(S)-Butan-2-yl]adenosine | N-[(S)-Butan-2-yl]adenosine | |
| N-[[(2S)-1-Butyl-2-pyrrolidinyl]methyl]-2-methoxy-5-sulfamoylbenzamide | N-[[(2S)-1-Butyl-2-pyrrolidinyl]methyl]-2-methoxy-5-sulfamoylbenzamide | |
| N-[3-[(S)-2-Butyrylamino-3-(4-hydroxy-3,5-diiodophenyl)propanoylamino]propyl]-N'-[3-[(S)-2-amino-4-guanidinobutyrylamino]propyl]butane-1,4-diamine | N-[3-[(S)-2-Butyrylamino-3-(4-hydroxy-3,5-diiodophenyl)propanoylamino]propyl]-N'-[3-[(S)-2-amino-4-guanidinobutyrylamino]propyl]butane-1,4-diamine | |
| NSCL protein | NSCL protein | |
| N-[[(2S)-1-Decylpyrrolidin-2α-yl]methyl]-2-methoxy-5-sulfamoylbenzamide | N-[[(2S)-1-Decylpyrrolidin-2α-yl]methyl]-2-methoxy-5-sulfamoylbenzamide | |
| N-(2-(S-coenzyme A)acetyl)spermidine | N-(2-(S-보효소A)아세틸)스페르미딘 | 83889-68-3 |
| NSC25872#NSC41835 | NSC25872#NSC41835 | 116-44-9 |
| N-[[[(5S)-5α-[[6-Deoxy-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6β,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen]-2-yl]carbonyl]-D-alanine methyl ester | N-[[[(5S)-5α-[[6-Deoxy-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6β,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen]-2-yl]carbonyl]-D-alanine methyl ester | |
| N-[[[(5S)-5α-[[6-Deoxy-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6β,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen]-2-yl]carbonyl]-D-alanine | N-[[[(5S)-5α-[[6-Deoxy-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6β,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen]-2-yl]carbonyl]-D-alanine | |
| Nα-[(2R)-2-(Morpholinocarbonylmethyl)-3-(1-naphthalenyl)propionyl]-L-His-[(2R,3S)-3-amino*-2-hydroxy-5-methylhexanoic acid]isopropyl ester | Nα-[(2R)-2-(Morpholinocarbonylmethyl)-3-(1-naphthalenyl)propionyl]-L-His-[(2R,3S)-3-amino*-2-hydroxy-5-methylhexanoic acid]isopropyl ester | |
| Nα-[(2R)-3-(Morpholinocarbonyl)-2-(1-naphtylmethyl)propionyl]-L-histidine methyl ester | Nα-[(2R)-3-(Morpholinocarbonyl)-2-(1-naphtylmethyl)propionyl]-L-histidine methyl ester | |
| NRN1 (full length)
| NRN1 (full length)
| |
| NSE | NSE | |
| NQ Y15 | NQ Y15 | |
| N,S-DIACETYL-L-CYSTEINE METHYL ESTER | N,S-디아세틸-L-시스테인메틸에스테르 | 19547-88-7 |
| N-[(1S)-4-(diaminomethylideneamino)-1-[(9-ethylcarbazol-3-yl)carbamoyl ]butyl]benzamide | N-[(1S)-4-(diaminomethylideneamino)-1-[(9-ethylcarbazol-3-yl)carbamoyl ]butyl]benzamide | 82576-33-8 |
| N,S-DIACETYLCYSTEAMINE | N,S-다이아세틸시스팀 | 1420-88-8 |
| N,S-DIACETYLCYSTEINE | N,S-DIACETYLCYSTEINE | |
| 3-N'-[(S)-3,6-Diaminohexanoyl]amphotericin B methyl ester | 3-N'-[(S)-3,6-Diaminohexanoyl]amphotericin B methyl ester | |
| (+)-N-[(S)-4-Diazo-1-methyl-3-oxobutyl]phthalimide | (+)-N-[(S)-4-Diazo-1-methyl-3-oxobutyl]phthalimide | |
| (+)-N-[(S)-4-Diazo-2-methyl-3-oxobutyl]phthalimide | (+)-N-[(S)-4-Diazo-2-methyl-3-oxobutyl]phthalimide | |
| 3-N'-[(S)-2,4-Diaminobutyryl]amphotericin B methyl ester | 3-N'-[(S)-2,4-Diaminobutyryl]amphotericin B methyl ester | |
| N-[(S)-1-(Diazoacetyl)-3-methylbutyl]-4-methylbenzenesulfonamide | N-[(S)-1-(Diazoacetyl)-3-methylbutyl]-4-methylbenzenesulfonamide | |
| N-[3-[(S)-2,6-Diaminohexanoylamino]propyl]-N'-[3-[(S)-2-butyrylamino-3-(4-hydroxy-3,5-diiodophenyl)propanoylamino]propyl]butane-1,4-diamine | N-[3-[(S)-2,6-Diaminohexanoylamino]propyl]-N'-[3-[(S)-2-butyrylamino-3-(4-hydroxy-3,5-diiodophenyl)propanoylamino]propyl]butane-1,4-diamine | |
| N-[3-[(S)-2,6-Diaminohexanoylamino]propyl]-N'-[3-[(S)-2-butyrylamino-3-[4-hydroxy-3,5-di[(125I)iodo]phenyl]propanoylamino]propyl]butane-1,4-diamine | N-[3-[(S)-2,6-Diaminohexanoylamino]propyl]-N'-[3-[(S)-2-butyrylamino-3-[4-hydroxy-3,5-di[(125I)iodo]phenyl]propanoylamino]propyl]butane-1,4-diamine | |
| (+)-N-[(S)-5-Diazo-3-methyl-4-oxopentyl]phthalimide | (+)-N-[(S)-5-Diazo-3-methyl-4-oxopentyl]phthalimide | |
| (-)-N-[(S)-6-Diazo-3-methyl-5-oxohexyl]phthalimide | (-)-N-[(S)-6-Diazo-3-methyl-5-oxohexyl]phthalimide | |
| (-)-N-[(S)-1-(Diazoacetyl)butyl]phthalimide | (-)-N-[(S)-1-(Diazoacetyl)butyl]phthalimide | |
| (-)-N-[(S)-α-Diazoacetyl-p-methoxyphenethyl]phthalimide | (-)-N-[(S)-α-Diazoacetyl-p-methoxyphenethyl]phthalimide | |
| (-)-N-[(S)-1,2-Dicyclohexylethyl]maleimide | (-)-N-[(S)-1,2-Dicyclohexylethyl]maleimide | |
| N-[(S)-1,2-Dicarboxyethyl]-D-glutamic acid | N-[(S)-1,2-디카르복시에틸]-D-글루탐산 | 90245-73-1 |
| (-)-N-[(S)-1,2-Di(cyclohexyl)ethyl]phthalimide | (-)-N-[(S)-1,2-Di(cyclohexyl)ethyl]phthalimide | |
| N-[2-[[(2S)-2α,6-Dicarboxy-1,2,3,4-tetrahydropyridin]-4-ylidene]ethylidene]glycine | N-[2-[[(2S)-2α,6-Dicarboxy-1,2,3,4-tetrahydropyridin]-4-ylidene]ethylidene]glycine | 135545-99-2 |
| (-)-N-[(S)-1,2-Dicyclohexylethyl]-2-methylenesuccinimide | (-)-N-[(S)-1,2-Dicyclohexylethyl]-2-methylenesuccinimide | |
| N-[(S)-1-(2,4-DICHLOROPHENYL)ETHYL]-2-CYANO-3,3-DIMETHYLBUTANAMIDE | N-[(S)-1-(2,4-DICHLOROPHENYL)ETHYL]-2-CYANO-3,3-DIMETHYLBUTANAMIDE | |
| N,S-DI(2,4-DNP)-L-CYSTEINE | N,S-DI(2,4-DNP)-L-시스테인 | 1655-62-5 |
| (-)-N-[(S)-α-Diethoxymethyl-p-methoxyphenethyl]phthalimide | (-)-N-[(S)-α-Diethoxymethyl-p-methoxyphenethyl]phthalimide | |
| N-[(1S)-2,3-dihydro-1H-inden-1-yl]-1H-pyrrolo[2,3-d]pyriMidin-4-aMine | N-[(1S)-2,3-dihydro-1H-inden-1-yl]-1H-pyrrolo[2,3-d]pyriMidin-4-aMine | 905580-86-1 |
| N-[[(S)-2,3-Dihydro-1H-inden]-1β-yl]adenosine | N-[[(S)-2,3-Dihydro-1H-inden]-1β-yl]adenosine | |
| N-[[(S)-2,3-Dihydro-5-methoxy-1H-inden]-1β-yl]adenosine | N-[[(S)-2,3-Dihydro-5-methoxy-1H-inden]-1β-yl]adenosine | |
| N-[(1S)-1-[[[(2,3-Dihydro-1H-inden)-2-yl][[[2-(trifluoroacetyl)propan-2-yl]carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide | N-[(1S)-1-[[[(2,3-Dihydro-1H-inden)-2-yl][[[2-(trifluoroacetyl)propan-2-yl]carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide | |
| (+)-N-[(S)-3,β-Dihydroxyphenethyl]-N-methylacetamide | (+)-N-[(S)-3,β-Dihydroxyphenethyl]-N-methylacetamide | |
| N-[[(S)-2,3-Dihydro-5-butoxy-1H-inden]-1β-yl]adenosine | N-[[(S)-2,3-Dihydro-5-butoxy-1H-inden]-1β-yl]adenosine | |
| (+)-N-[(S)-β,3-Dihydroxy-4-nitrophenethyl]-N-methylacetamide | (+)-N-[(S)-β,3-Dihydroxy-4-nitrophenethyl]-N-methylacetamide | |
| N-[(1S)-1-[[[(2,3-Dihydro-1H-inden)-2-yl][[(2-oxo-3,3,3-trifluoropropyl)carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide | N-[(1S)-1-[[[(2,3-Dihydro-1H-inden)-2-yl][[(2-oxo-3,3,3-trifluoropropyl)carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide | |
| NSD2 (human recombinant) | NSD2 (human recombinant) | |
| N1-[(1S)-2,2-Dimethyl-1-[[[(1R)-1-phenylethyl]amino]carbonyl]propyl]-N4-hydroxy-2-[3-(2-methyl[1,1'-biphenyl]-4-yl)propyl]-butanediamine | N1-[(1S)-2,2-Dimethyl-1-[[[(1R)-1-phenylethyl]amino]carbonyl]propyl]-N4-hydroxy-2-[3-(2-methyl[1,1'-biphenyl]-4-yl)propyl]-butanediamine | 230961-08-7 |
| N-[(20S)-20-(Dimethylamino)-16β-hydroxy-4,4,14-trimethyl-11-oxo-9,19-cyclo-5α-pregnan-3β-yl]benzamide | N-[(20S)-20-(Dimethylamino)-16β-hydroxy-4,4,14-trimethyl-11-oxo-9,19-cyclo-5α-pregnan-3β-yl]benzamide | 15524-62-6 |
| N-[(20S)-4,14-Dimethyl-20-(dimethylamino)-16β-hydroxy-4β-(hydroxymethyl)-9β,19-cyclo-5α-pregnan-3β-yl]benzamide | N-[(20S)-4,14-Dimethyl-20-(dimethylamino)-16β-hydroxy-4β-(hydroxymethyl)-9β,19-cyclo-5α-pregnan-3β-yl]benzamide | 17934-60-0 |
| N-[(5S,6β,7β,10α)-2,10-Dimethyl-7-isopropylspiro[4.5]dec-1-en-6-yl]formamide | N-[(5S,6β,7β,10α)-2,10-Dimethyl-7-isopropylspiro[4.5]dec-1-en-6-yl]formamide | |
| (-)-N-[(S)-1-(5,8-Dimethyl-2-naphtyl)ethyl]benzamide | (-)-N-[(S)-1-(5,8-Dimethyl-2-naphtyl)ethyl]benzamide | |
| N-[(2S)-2,4-Dimethyl-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide | N-[(2S)-2,4-Dimethyl-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide | |
| N-[[S,(+)]-2-(3,3-Dimethylpiperidino)-1-methylethyl]-N-(2-pyridyl)propionamide | N-[[S,(+)]-2-(3,3-디메틸피페리디노)-1-메틸에틸]-N-(2-피리딜)프로피온아미드 | 24608-95-5 |
| N-[(2S)-2,4-Dimethyl-2-[[[(2S)-pyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide | N-[(2S)-2,4-Dimethyl-2-[[[(2S)-pyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide | |
| (-)-N-[(S)-1-(3,4-Dimethoxybenzoyl)ethyl]phthalimide | (-)-N-[(S)-1-(3,4-Dimethoxybenzoyl)ethyl]phthalimide | |
| (+)-N-[(S)-3,4-Dimethoxy-α-methylphenethyl]-p-toluenesulfonamide | (+)-N-[(S)-3,4-Dimethoxy-α-methylphenethyl]-p-toluenesulfonamide | |
| N-[(20S)-20-(Dimethylamino)-16α-hydroxy-4α-(hydroxymethyl)-4,14-dimethyl-11-oxo-9β,19-cyclo-5α-pregnan-3β-yl]-2-methylpropanamide | N-[(20S)-20-(Dimethylamino)-16α-hydroxy-4α-(hydroxymethyl)-4,14-dimethyl-11-oxo-9β,19-cyclo-5α-pregnan-3β-yl]-2-methylpropanamide | 4947-53-9 |
| (+)-N-[(S)-1,2-Dimethylpropyl]-4-nitrobenzamide | (+)-N-[(S)-1,2-Dimethylpropyl]-4-nitrobenzamide | |
| N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-2,2-DIMETHYLPROPANAMIDE | N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-2,2-DIMETHYLPROPANAMIDE | |
| N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-2,2-DIPHENYLACETAMIDE | N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-2,2-DIPHENYLACETAMIDE | |
| N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-4-(ETHYLTHIO)BENZAMIDE | N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-4-(ETHYLTHIO)BENZAMIDE | |
| N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-4-NITROBENZAMIDE | N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-4-NITROBENZAMIDE | |
| N4-{[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}pyrimidine-4,5-diamine | N4-{[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}pyrimidine-4,5-diamine | |